Digital Breast Tomosynthesis Equipment Market, by Product Type (Equipment, and Upgradation) By End User (Hospitals, and Diagnostic Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : May 2023

Code : CMI3445

Pages :95

Formats :

Excel and PDF

Industry : Medical Devices

Market News

Global Digital Breast Tomosynthesis Equipment Market: Key Developments

On March 20 2023, Lunit, Inc., a medical artificial intelligence (AI) software company, announced that its AI solution for 3D Breast Tomosynthesis (DBT) analysis, Lunit INSIGHT DBT, has met the requirements of the CE marking under Europe's latest Medical Device Regulation (MDR). The MDR CE certification is a more stringent requirement for medical devices than the existing Medical Device Directive (MDD), ensuring higher performance and quality standards.

In December 2021, Freenome Holdings, Inc., a privately held biotech company, announced a partnership with Siemens Healthineers to collaborate in multiomics and radiomic breast cancer diagnostics to identify suitable markers for early breast cancer detection through blood to augment existing imaging technologies. The partnership leverages Freenome's expertise in machine learning and multiomics to detect early cancer, utilizing epigenetic, proteomic, genomic, immunologic and other data types to maximize clinical accuracy for future screening tests. This collaboration will allow Freenome and Siemens Healthineers to share their technologies by connecting imaging and clinical data with molecular data to identify new suitable markers of breast cancer that are complementary to those identified using current imaging.

In November 2021, Arterys, Inc., a medical imaging AI platform, announced it signed a global distribution agreement with iCAD, a global medical technology providing innovative cancer detection and therapy solutions. This partnership will expand access to iCAD's industry-leading AI-powered breast health solutions via Arterys' U.S. FDA-cleared and CE-marked MICA platform to its installed base.

In December 2022, GigCapital5, Inc., a publicly traded special purpose acquisition company, and QT Imaging, Inc., a medical imaging company that develops novel products for body imaging, announced that they have entered into a definitive business combination agreement that would result in QT Imaging becoming a publicly listed company subject to closing. Upon closing of the transaction, the combined company will be named QT Imaging Holdings, Inc. and will be traded on the NYSE under the new ticker symbol “QTI”. The goal is to complete the business combination in the first half of 2023.

On January 31 2023, Abdul Latif Jameel IPR Company Limited, operates as a holding company and provides a range of products and services, including the wholesale distribution of vehicles, consumer financing services, and full service advertising announced a new distribution agreement with iSono Health, a medical technology company in San Francisco, USA, to transform breast care with automated imaging and artificial intelligence (AI).